Projects per year
Personal profile
Education
- 2012 PhD, Institute of Clinical Medicine, National Cheng Kung University
Experience
- 2005.7~Present Attending Physician, Department of Internal Medicine, NCKUH
- 2013.2~2015.8 Clinical Assistant professorr/Department of Internal Medicine, NCKU
- 2015.8~present Assistant Professor/Institute of Clinical Medicine, NCKU
Research Interests
- Clinical Oncology
- Anti-Cancer Pharmacology
- DNA Repair and Anti-Oxidant Stress in Oncology
- Cellular Resistance to Anti-Cancer Therapy and its Clinical Application
Fingerprint Dive into the research topics where Wen-Pin Su is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Lung Neoplasms
Medicine & Life Sciences
Non-Small Cell Lung Carcinoma
Medicine & Life Sciences
STAT3 Transcription Factor
Medicine & Life Sciences
docetaxel
Medicine & Life Sciences
Cisplatin
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Survival
Medicine & Life Sciences
Malignant Pleural Effusion
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2008 2018
- 10 Finished
PD-L1不只是Biomarker！探討肺癌細胞本身的PD-L1促進轉移的機轉，及其與TIP60-mediated 癌症EMT的相關性
17-08-01 → 18-07-31
Project: Research project
PD-L1在肺癌的探索及其治療應用—與 mTOR inhibitor，DNA damage agents及DNA修補蛋白MORF 的相關性
16-08-01 → 17-07-31
Project: Research project
Research Output 2005 2018
Excellent treatment response with pembrolizumab in a lung cancer patient who developed immune-mediated acute motor/sensory axonal polyneuropathy
Yen, C. C., Su, H-C., Chu, C-Y., Lai, S. J., Yan, J. J., Su, W-P. & Su, W-C., 2018 Jun 1, In : Lung Cancer. 120, p. 149-151 3 p.Research output: Contribution to journal › Letter
Polyneuropathies
Lung Neoplasms
Therapeutics
pembrolizumab
3
Citations
(Scopus)
Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways
Su, W-P., Ho, Y. C., Wu, C. K., Hsu, S. H., Shiu, J. L., Huang, J. C., Chang, S-B., Chiu, W-T., Hung, J-J., Liu, T., Wu, W-S., Wu, P. Y., Su, W-C., Chang, J-Y. & Liaw, H-J., 2017 Dec 1, In : Scientific reports. 7, 1, 3879.Research output: Contribution to journal › Article
Fanconi Anemia
Recombinational DNA Repair
Cisplatin
Fanconi Anemia Complementation Group D2 Protein
Genes
56
Citations
(Scopus)
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial
RANGE study investigators, 2017 Nov 18, In : The Lancet. 390, 10109, p. 2266-2277 12 p.Research output: Contribution to journal › Article
docetaxel
Platinum
Placebos
Carcinoma
Therapeutics
2
Citations
(Scopus)
Combined interactions of plant homeodomain and chromodomain regulate NuA4 activity at DNA double-strand breaks
Su, W. P., Hsu, S. H., Chia, L. C., Lin, J. Y., Chang, S. B., Jiang, Z. D., Lin, Y. J., Shih, M. Y., Chen, Y. C., Chang, M. S., Yang, W. B., Hung, J. J., Hung, P. C., Wu, W. S., Myung, K. & Liaw, H., 2016 Jan, In : Genetics. 202, 1, p. 77-92 16 p.Research output: Contribution to journal › Article
Double-Stranded DNA Breaks
Acetylation
Histones
Mutation
Bleomycin
11
Citations
(Scopus)
Huntingtin-interacting protein-1 is an early-stage prognostic biomarker of lung adenocarcinoma and suppresses metastasis via AKT-mediated epithelial-mesenchymal transition
Hsu, C. Y., Lin, C. H., Jan, Y. H., Su, C. Y., Yao, Y. C., Cheng, H. C., Hsu, T. I., Wang, P. S., Su, W. P., Yang, C. J., Huang, M. S., Calkins, M. J., Hsiao, M. & Lu, P. J., 2016 Apr 15, In : American Journal of Respiratory and Critical Care Medicine. 193, 8, p. 869-880 12 p.Research output: Contribution to journal › Article
Epithelial-Mesenchymal Transition
Biomarkers
Neoplasm Metastasis
Non-Small Cell Lung Carcinoma
Adenocarcinoma
Thesis
Interaction between secreted protein acidic and rich in cysteine (SPARC) and programmed death ligand 1 (PD-L1) promotes EMT program via WNK1 activation in lung adenocarcinoma
Author: 立展, 張., 2018 Aug 15Supervisor: Su, W. (Supervisor)
Student thesis: Master's Thesis
The intrinsic PD-L1 promotes cellular invasiveness via their PD-1 receptor in lung adenocarcinoma cells
Author: 舜如, 楊., 2017 Aug 25Supervisor: Su, W. (Supervisor)
Student thesis: Master's Thesis